Y. Miyata

发表

Incidence of venous thromboembolism in patients with solid cancers in Japan: retrospective study of 2735 patients

H. Minami, N. Kiyota, Y. Imamura, 2021, International Journal of Hematology.

Apixaban in Japanese patients with cancer-associated venous thromboembolism: a multi-center phase II trial

H. Matsuoka, K. Otsui, H. Minami, 2022, International Journal of Hematology.

An mTORC1/2 dual inhibitor, AZD2014, acts as a lysosomal function activator and enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells

H. Matsuoka, Aki Inase, H. Minami, 2019, International Journal of Hematology.

Tolvaptan as an alternative treatment for refractory fluid retention associated with sinusoidal obstruction syndrome after allogeneic stem cell transplantation

H. Matsuoka, Katsuya Yamamoto, H. Minami, 2013, International Journal of Hematology.

Inhaled corticosteroids do not affect the antibody titer against the SARS-CoV-2 spike protein in BNT162b2 mRNA vaccinated patients

Y. Nishimura, Kazuyuki Kobayashi, K. Yakushijin, 2022, Allergy, Asthma & Clinical Immunology.

A novel TRB@/NOTCH1 fusion gene in T‐cell lymphoblastic lymphoma with t(7;9)(q34;q34)

H. Matsuoka, Katsuya Yamamoto, S. Kawano, 2013, European journal of haematology.

Global longitudinal strain is superior to ejection fraction for long‐term follow‐up after allogeneic hematopoietic stem cell transplantation

H. Matsuoka, Katsuya Yamamoto, Mitsuhiro Ito, 2021, EJHaem.

A prospective study of the antiemetic effect of palonosetron in malignant lymphoma patients treated with the CHOP regimen

H. Matsuoka, Katsuya Yamamoto, H. Minami, 2016, International Journal of Hematology.

Successful Bridging Chemotherapy with Gemcitabine, Carboplatin, and Dexamethasone before Unrelated Stem Cell Transplantation for Hepatosplenic T-cell Lymphoma

H. Matsuoka, Katsuya Yamamoto, H. Minami, 2018, Internal medicine.

Invasive Scopulariopsis alboflavescens infection in patient with acute myeloid leukemia

H. Matsuoka, Katsuya Yamamoto, K. Kamei, 2018, International Journal of Hematology.

Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft‐versus‐host disease after allogeneic hematopoietic stem cell transplantation

H. Matsuoka, Katsuya Yamamoto, H. Minami, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

CD56-positive diffuse large B-cell lymphoma: possible association with extranodal involvement and bcl-6 expression

C. Obayashi, Katsuya Yamamoto, T. Murayama, 2010, Hematology.

Pharmacokinetics of intravenous mycophenolate mofetil in allogeneic hematopoietic stem cell-transplanted Japanese patients

H. Matsuoka, H. Minami, T. Murayama, 2018, Cancer Chemotherapy and Pharmacology.

Early lymphocyte recovery predicts clinical outcome after HSCT with mycophenolate mofetil prophylaxis in the Japanese population

H. Matsuoka, Katsuya Yamamoto, H. Minami, 2018, International Journal of Hematology.

An mTORC1/2 kinase inhibitor enhances the cytotoxicity of gemtuzumab ozogamicin by activation of lysosomal function.

H. Matsuoka, Y. Shimono, Aki Inase, 2018, Leukemia research.

A Case of Classical Hodgkin Lymphoma with Total Lymph Node Infarction.

H. Matsuoka, Katsuya Yamamoto, H. Minami, 2018, Journal of Clinical and Experimental Hematopathology.

GSK3 inhibitor enhances gemtuzumab ozogamicin‐induced apoptosis in primary human leukemia cells by overcoming multiple mechanisms of resistance

H. Matsuoka, Aki Inase, H. Minami, 2022, EJHaem.

The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation

H. Matsuoka, G. Ohji, H. Minami, 2022, Vaccines.

Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in Japanese patients after allogeneic stem cell transplantation.

H. Matsuoka, G. Ohji, A. Kitao, 2021, medRxiv.

NANOG Expression as a Responsive Biomarker during Treatment with Hedgehog Signal Inhibitor in Acute Myeloid Leukemia

H. Matsuoka, H. Minami, K. Yakushijin, 2017, International journal of molecular sciences.

Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination

H. Matsuoka, G. Ohji, Katsuya Yamamoto, 2022, Vaccines.

Expression of a novel type of KMT2A/EPS15 fusion transcript in FLT3 mutation-positive B-lymphoblastic leukemia with t(1;11)(p32;q23).

H. Matsuoka, Katsuya Yamamoto, J. Saegusa, 2021, Cancer genetics.

Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody

H. Matsuoka, G. Ohji, Katsuya Yamamoto, 2022, International Journal of Hematology.

Early diagnosis of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation, with modified diagnostic criteria including refractory thrombocytopenia

H. Matsuoka, Katsuya Yamamoto, H. Minami, 2023, eJHaem.

Unbalanced Translocation der(7)t(7q;11q): A New Recurrent Aberration Leading to Partial Monosomy 7q and Trisomy 11q in Acute Myeloid Leukemia

H. Matsuoka, Katsuya Yamamoto, H. Minami, 2014, Acta Haematologica.

Safety and Accuracy of Professional Continuous Glucose Monitoring in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

H. Matsuoka, Y. Hirota, Katsuya Yamamoto, 2023, Blood cell therapy.

Cellular immunity reflects the persistent symptoms among COVID-19 recovered patients in Japan

H. Matsuoka, Y. Miyata, T. Nagano, 2023, Scientific reports.

Extramedullary T-lymphoid blast crisis of an ETV6/ABL1-positive myeloproliferative neoplasm with t(9;12)(q34;p13) and t(7;14)(p13;q11.2)

H. Matsuoka, Y. Hayashi, Katsuya Yamamoto, 2014, Annals of Hematology.

Cytomegalovirus Oophoritis Mimicking Burkitt's Lymphoma Recurrence: A Case Report and Literature Review

Y. Miyata, Seiji Kakiuchi, Ikumi Takagi, 2022, Internal medicine.

Phase III clinical trial of autologous CD34 + cell transplantation to accelerate fracture nonunion repair

R. Kuroda, Tomoyuki Matsumoto, T. Niikura, 2023, BMC Medicine.